Harnessing Drug Repurposing to Combat Breast Cancer by Targeting Altered Metabolism and Epithelial-to-Mesenchymal Transition Pathways
Breast cancer remains one of the most prevalent and challenging cancers to treat due to its
complexity and heterogenicity. Cellular processes such as metabolic reprogramming and …
complexity and heterogenicity. Cellular processes such as metabolic reprogramming and …
The role of statins in breast cancer survivors
SZ Bashey, A Kordon, K Ositelu, A Rao… - Breast Cancer Research …, 2025 - Springer
Purpose As breast cancer survival rates improve, cardiovascular disease (CVD) has
become a critical concern among survivors due to co-morbidities and the cardiotoxic effects …
become a critical concern among survivors due to co-morbidities and the cardiotoxic effects …